Pregnancy: Pregestational and Gestational Management
Gestational diabetes (GD) is a complication of pregnancy with an incidence of up to 16%, characterized by alteration in carbohydrate metabolism. It is a condition that favors greater risk of developing complications such as congenital malformations, stillbirth, preeclampsia, fetal macrosomia, polyhydramnios, greater index of cesareans, and hemorrhagic complications that it brings. Its etiology is multifactorial, including genetic determinants such as ethnicity; lifestyle, where sedentary lifestyle plays the most important role; easy access to high-caloric foods; and the socioeconomic level, where the lower strata have the highest risk. Diagnosis is easy to perform from the identification of women of reproductive age with risk factors and from the first prenatal visit, by measuring blood glucose. General measures such as lifestyle and diet modification of the pregnant patient are the beginning of treatment. In the case of not reaching control of glucose levels, oral hypoglycemic drug and insulin are the basis of treatment with the object of maximum reduction of complications for both mother and neonate.
KeywordsDiabetes Pregnancy Gestational diabetes Obesity Pregnancy outcomes
The American College of Obstetricians and Gynecologists.
The American Diabetes Association.
Is the result of dividing the weight of a person in kilograms by the square of his height in meters.
are anatomic alterations that occur in the intrauterine stage and may be alterations in organs, extremities or systems, due to environmental, genetic factors, deficiencies in nutrient capture, or consumption of noxious substances.
National Health and Nutrition Survey 2012 (Mexico).
The Food and Drug Administration.
Traditionally, fetal macrosomia has been defined as arbitrary weight at birth, such as 4000, 4100, 4500, or 4536 grams. It is currently defined as a fetus that is large for gestational age (> 90 percentile).
Gestational diabetes, which is defined as alteration in carbohydrate metabolism diagnosed for the first time in the second or third trimester of gestation.
Hyperglycemia and Adverse Pregnancy Outcomes study.
The International Association of Diabetes and Pregnancy Study Groups.
From the Latin “isla.” It is a polypeptide hormone formed by 51 amino acids, produced and secreted by the beta cells of the Islets of Langerhans of the pancreas. Discovered by Frederick Grant Banting, Charles Best, James Collip, and J.J.R. Macleod of the University of Toronto, Canada in 1921.
National Institutes of Health.
Obesity and overweight are defined as abnormal or excessive accumulation of fat that may prejudice health. A simple way to measure obesity is the body mass index (BMI), which is the weight of a person divided by height in meters squared. A person with BMI equal or above 30 is considered obese and with a BMI equal or greater than 25 is considered overweight.
Antidiabetic drugs which are classified as sulfonylureas, biguanides, alpha-glucosidase inhibitors, meglitinides (repaglinide, nateglinide) and thiazolidinediones.
is the fetus and newborn risk of dying as a consequence of the reproductive process.
According to WHO, birth that occurs after week 20 and before 37 complete weeks.
Type 1 diabetes, which is secondary to the destruction of the beta cells of the pancrease, and in general leads to absolute insulin deficiency.
Type 2 diabetes, which is due to a progressive loss of insulin secretion.
World Health Organization.
Women between 15 and 44 years.
- 4.ACOG. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol. 2013;122(2 Pt 1):406–16.Google Scholar
- 9.American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In standards of medical care in diabetes 2016. Diabetes Care. 2016;39(Suppl. 1):S13–22.Google Scholar
- 12.Ogunyemi DA, Fong A, Rad S, Fong S, Kjos SL. Attitudes and practices of health care providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28(8):976–86.CrossRefGoogle Scholar
- 13.Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23. https://doi.org/10.1186/1471-2393-12-23.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.American Diabetes Association. Management of diabetes in pregnancy. Sec. 12. In standards of medical care in diabetes. Diabetes Care. 2016;39(Suppl 1):S94–8.Google Scholar
- 16.Buchanan TA. Intermediary metabolism durin pregnancy: implication for diabtes mellitus. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Quest Library. pp. 1237–50.Google Scholar
- 17.Buchanan TA. Effects of maternal diabetes mellitus on intrauterine development. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Qeust ebrary. pp. 1251–64.Google Scholar
- 19.Guía de Práctica Clínica. Diagnóstico y Tratamiento de la Diabetes en el Embarazo. México: Secretaria de Salud; 2009.Google Scholar